Related Experiment Videos
[Fibrinolysis in right ventricular thrombus]
Summary
A 34-year-old male experienced deep leg vein thrombosis and pulmonary embolism after a toe fracture. Fibrinolytic therapy for a right ventricular thrombus proved dangerous, leading to a fatal outcome, suggesting surgical thrombectomy may be safer.
Area of Science:
- Cardiology
- Vascular Surgery
- Critical Care Medicine
Background:
- Deep vein thrombosis (DVT) and pulmonary embolism (PE) can arise from various causes, including trauma.
- Right ventricular thrombosis is a rare but serious complication, often associated with DVT and PE.
- Echocardiography is crucial for diagnosing intracardiac masses and assessing their impact on cardiac function.
Observation:
- A 34-year-old male presented with DVT and PE following toe fractures.
- Echocardiography revealed a large (4.5 cm x 3.5 cm) mobile mass in the right ventricle, suspected to be a thrombus.
- Despite heparin therapy, the patient's condition worsened, necessitating fibrinolytic treatment with streptokinase.
Findings:
- Fibrinolytic therapy initially improved pulmonary gas exchange but was followed by progressive cardiopulmonary insufficiency and death.
- Necropsy confirmed a right ventricular thrombus, smaller than visualized on echocardiography, with surface erosions from fibrinolysis.
- Pulmonary vessels showed multiple fragmented emboli, indicating a potential fragmentation of the right ventricular thrombus.
Implications:
- This case highlights the potential risks of fibrinolytic therapy in managing right ventricular thrombosis.
- Fibrinolysis may lead to dangerous fragmentation of the thrombus, causing lethal pulmonary emboli.
- Surgical thrombectomy might be a safer alternative to fibrinolysis for right ventricular thrombosis, especially in severe cases.